X4 Pharmaceuticals, Inc. (XFOR) Social Stream
X4 PHARMACEUTICALS INC (XFOR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering XFOR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 7 | $27 | $15 | $19.333 | $0.84 | 2201.55% |
| 2021-12-14 | 7 | $27 | $11 | $17.666 | $0.84 | 2003.1% |
| 2021-12-16 | 7 | $27 | $10 | $16.833 | $0.84 | 1903.93% |
| 2021-12-19 | 7 | $28 | $10 | $17 | $0.84 | 1923.81% |
| 2022-01-03 | 6 | $28 | $10 | $17.333 | $0.84 | 1963.45% |
| 2022-03-18 | 7 | $28 | $10 | $16.166 | $0.84 | 1824.52% |
| 2022-03-21 | 7 | $28 | $10 | $14.166 | $0.84 | 1586.43% |
| 2022-05-12 | 7 | $28 | $10 | $13.571 | $0.84 | 1515.6% |
| 2022-05-13 | 7 | $28 | $8 | $12.357 | $0.84 | 1371.07% |
| 2022-05-19 | 7 | $28 | $7 | $11.928 | $0.84 | 1320% |
| 2022-08-04 | 6 | $10 | $5 | $7.5 | $0.84 | 792.86% |
| 2022-08-05 | 6 | $10 | $3.5 | $6.666 | $0.84 | 693.57% |
| 2022-11-03 | 6 | $10 | $3.5 | $6.166 | $0.84 | 634.05% |
| 2022-11-29 | 6 | $10 | $3.5 | $6.333 | $0.84 | 653.93% |
| 2022-11-30 | 6 | $10 | $5 | $6.583 | $0.84 | 683.69% |
| 2022-12-08 | 7 | $10 | $4.5 | $6.25 | $0.84 | 644.05% |
| 2022-12-12 | 7 | $10 | $3 | $5.785 | $0.84 | 588.69% |
| 2022-12-22 | 8 | $10 | $3 | $5.437 | $0.84 | 547.26% |
| 2023-03-22 | 8 | $10 | $3 | $5.187 | $0.84 | 517.5% |
| 2023-03-24 | 8 | $7 | $3 | $4.071 | $0.84 | 384.64% |
| 2023-05-08 | 8 | $4.5 | $3 | $3.5 | $0.84 | 316.67% |
| 2023-05-21 | 8 | $5 | $2.6 | $3.514 | $0.84 | 318.33% |
| 2023-05-22 | 8 | $5 | $2.6 | $3.657 | $0.84 | 335.36% |
| 2023-08-11 | 8 | $5 | $2.6 | $3.762 | $0.84 | 347.86% |
| 2023-08-15 | 8 | $5 | $2.6 | $3.585 | $0.84 | 326.79% |
| 2023-11-14 | 8 | $5 | $2.6 | $3.512 | $0.84 | 318.1% |
| 2023-12-15 | 8 | $5 | $1 | $3.2 | $0.84 | 280.95% |
The Trend in the Analyst Price Target
XFOR's average price target has moved down $16.21 over the prior 30 months.
XFOR reports an average of 279% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-10 | 8 | 4.5 | 3.0 | 3.500 | 0.870 | 302.3% |
| 2023-05-21 | 8 | 5.0 | 2.6 | 3.514 | 2.100 | 67.33% |
| 2023-05-22 | 8 | 5.0 | 2.6 | 3.657 | 2.185 | 67.37% |
| 2023-08-11 | 8 | 5.0 | 2.6 | 3.762 | 1.280 | 193.91% |
| 2023-12-15 | 7 | 5.0 | 1.0 | 3.200 | 0.714 | 348.18% |
XFOR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 7 | 0 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 36 months, XFOR's average broker recommendation rating improved by 0.25.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- XFOR has a higher upside potential (average analyst target price relative to current price) than 3616.76% of all US stocks.
- X4 PHARMACEUTICALS INC's average analyst price target is greater than 355.46% of all US stocks.
- XFOR has a greater number of analysts covering the stock than 3086.56% of stocks in the small market cap category.
- In the context of stocks in the small market cap category, X4 PHARMACEUTICALS INC's variance in analysts' estimates is lower than -2972.63% of them.
Stocks similar to X4 PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are APTO, CLLS, and ADAP.
View All Top Stocks by Price Target
Is XFOR a Buy, Hold or Sell? See the POWR Ratings now!